We are thrilled to welcome Darren Eckberg to Lark as our new Chief Growth Officer! As employers, payers and PBMs struggle to curb the budget pressures that GLP-1 medication demand has inflicted upon the healthcare industry, we believe Darren is the perfect addition to lead our national expansion of our AI-guided, GLP-1 cost containment technology. When asked his thoughts on joining the organization, Darren says, “I’m honored to be joining the Lark team and am thrilled to help millions of Americans struggling with a chronic condition. As one of the pioneers in AI health tech, Lark’s spirit for innovation is complemented by a dedication to clinical excellence and being a responsible partner for our clients. The impacts of GLP-1 medications affect the entire healthcare system and a thoughtfully designed end-to-end offering can benefit everyone from the individual member struggling with obesity to the employer struggling with the skyrocketing GLP-1 costs.” Learn more about Darren's background and our recent expansion: https://ow.ly/Zri750Rje61
congrats
Congratulations
Congratulations!!!!!!!
Congratulations, Darren! I thought I saw you in New Orleans on Tuesday, however I couldn’t find you again :-). Best of luck with your new position.
Congratulations Darren! They are lucky to have you! 🎉
Congrats, Darren!! Wishing you happiness in your new position.
Congratulations!
Congratulations Darren. Excited to see the growth journey you take Lark on!
Congrats Darren Eckberg!
Congratulations Darren Eckberg. Best of luck with your healthcare goals. They will definitely benefit patients, caregivers, providers and employer clients. Tremendous amount of noise around the GLP-1 category, and managing it more closely is a necessity.